tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PALI Stock Latest News

Palisade Bio appoints Sharon Skare as global head, clinical operations
The FlyPalisade Bio appoints Sharon Skare as global head, clinical operations
4d ago
PALI
Palisade Bio Terminates Phantom Unit Plan
PremiumCompany Announcements
Palisade Bio Terminates Phantom Unit Plan
10d ago
8K
PALI
Palisade Bio Approves Reverse Stock Split Amendment
PremiumCompany Announcements
Palisade Bio Approves Reverse Stock Split Amendment
12d ago
8K
PALI
Palisade Bio announces first patients dosed in Phase 1b study of PALI-2108
PremiumThe Fly
Palisade Bio announces first patients dosed in Phase 1b study of PALI-2108
12d ago
PALI
Palisade Bio Regains Nasdaq Compliance on Stock Price
PremiumCompany Announcements
Palisade Bio Regains Nasdaq Compliance on Stock Price
16d ago
8K
PALI
Palisade Bio granted Canadian patent covering PALI-2108 composition
PremiumThe FlyPalisade Bio granted Canadian patent covering PALI-2108 composition
19d ago
PALI
Palisade Bio Cancels Stockholder Meeting Due to Quorum
Premium
Company Announcements
Palisade Bio Cancels Stockholder Meeting Due to Quorum
23d ago
8K
PALI
Palisade Bio prices 171.4M shares at 70c in upsized underwritten public offering
Premium
The Fly
Palisade Bio prices 171.4M shares at 70c in upsized underwritten public offering
1M ago
PALI
Palisade Bio files to sell 147.1M shares of common stock
PremiumThe Fly
Palisade Bio files to sell 147.1M shares of common stock
1M ago
PALI
Palisade Bio Adjourns Stockholder Meeting Due to Quorum
PremiumCompany Announcements
Palisade Bio Adjourns Stockholder Meeting Due to Quorum
1M ago
8K
PALI
Palisade Bio Reschedules Stockholder Meeting Due to Quorum Issue
PremiumCompany Announcements
Palisade Bio Reschedules Stockholder Meeting Due to Quorum Issue
1M ago
8K
PALI
Optimistic Buy Rating for Palisade Bio: Promising Clinical Trials and Strategic Market Expansion
PremiumRatings
Optimistic Buy Rating for Palisade Bio: Promising Clinical Trials and Strategic Market Expansion
1M ago
PALI
Palisade Bio reports results from PALI-2108 Phase 1b data
PremiumThe FlyPalisade Bio reports results from PALI-2108 Phase 1b data
2M ago
PALI
Palisade Bio Launches Phantom Unit Plan for Employees
Premium
Company Announcements
Palisade Bio Launches Phantom Unit Plan for Employees
2M ago
8K
PALI
Palisade Bio receives Health Canada clearance for Phase 1b PALI-2108 trial
Premium
The Fly
Palisade Bio receives Health Canada clearance for Phase 1b PALI-2108 trial
2M ago
PALI
Palisade Bio releases virtual KOL Connect segment on PALI-2108
PremiumThe Fly
Palisade Bio releases virtual KOL Connect segment on PALI-2108
2M ago
PALI
Palisade Bio: Buy Rating Backed by Financial Stability and Promising Clinical Trial Results
PremiumRatings
Palisade Bio: Buy Rating Backed by Financial Stability and Promising Clinical Trial Results
2M ago
PALI
Palisade Bio files to sell 8.9M shares of common stock for holders
PremiumThe Fly
Palisade Bio files to sell 8.9M shares of common stock for holders
3M ago
PALI
Palisade Bio’s Strategic Positioning and Promising Trial Results Earn Buy Rating
PremiumRatings
Palisade Bio’s Strategic Positioning and Promising Trial Results Earn Buy Rating
3M ago
PALI
Palisade Bio’s PALI-2108: A Promising New Treatment for Ulcerative Colitis
PremiumCompany AnnouncementsPalisade Bio’s PALI-2108: A Promising New Treatment for Ulcerative Colitis
3M ago
PALI
Palisade Bio announces new data from ongoing program evaluating PALI-2108
Premium
The Fly
Palisade Bio announces new data from ongoing program evaluating PALI-2108
3M ago
PALI
Palisade Bio receives notice of allowance for patent of PALI-2108 in China
Premium
The Fly
Palisade Bio receives notice of allowance for patent of PALI-2108 in China
3M ago
PALI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >